Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells
End of Embargo2021-08-26
Abu Ras, Bayan
Rights© 2020 Taylor & Francis. This is an Author's Original Manuscript of an article published by Taylor & Francis in Expert Opinion on Drug Delivery on 15 Sep 2020 available online at https://doi.org/10.1080/17425247.2020.1813714.